Biostage, Inc. Common Stock
BSTG
BSTG was delisted on the 5th of October, 2017.
51 hedge funds and large institutions have $30.4M invested in Biostage, Inc. Common Stock in 2014 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 13 increasing their positions, 14 reducing their positions, and 9 closing their positions.
82% more capital invested
Capital invested by funds: $16.7M → $30.4M (+$13.7M)
7% less repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 14
4% less funds holding
Funds holding: 53 → 51 (-2)
22% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 9
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PAIM
Punch & Associates Investment Management
Edina,
Minnesota
|
+$728K |
| 2 |
6CM
683 Capital Management
New York
|
+$594K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$230K |
| 4 |
TC
TFS Capital
West Chester,
Pennsylvania
|
+$138K |
| 5 |
PPA
Parametric Portfolio Associates
Seattle,
Washington
|
+$133K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
-$473K |
| 2 |
Fuller & Thaler Asset Management
San Mateo,
California
|
-$430K |
| 3 |
Renaissance Technologies
New York
|
-$336K |
| 4 |
MOACM
Mutual of America Capital Management
New York
|
-$309K |
| 5 |
JG
Jefferies Group
New York
|
-$238K |
BSTG Hedge Fund Activity: Q1 2014 in Review
51 of the 3,475 institutional investors tracked by Wall St. Rank reported a position in Biostage, Inc. Common Stock (BSTG) for Q1 2014, worth a combined $30.4M — up 82% from $16.7M a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of BSTG and 7 opened new positions — a net loss of 2 holders — while 14 trimmed existing stakes and 13 added.
The largest buyer was Punch & Associates Investment Management, adding an estimated $728K. The largest seller was BlackRock Institutional Trust, cutting an estimated $473K.
- 51 institutional investors held Biostage, Inc. Common Stock (BSTG) as of Q1 2014, down from 53 in Q4 2013.
- Funds reported $30.4M of Biostage, Inc. Common Stock stock for Q1 2014, up 82% quarter-over-quarter.
- 7 funds opened new Biostage, Inc. Common Stock positions in Q1 2014 and 9 closed out, a net change of -2 holders.
- The largest Biostage, Inc. Common Stock buyer in Q1 2014 was Punch & Associates Investment Management, an estimated $728K added.
- The largest Biostage, Inc. Common Stock seller in Q1 2014 was BlackRock Institutional Trust, an estimated $473K sold.
Based on aggregated 13F filings for Q1 2014.